BioSpace News Archive

Drug Development

Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors

July 8, 2024
·
4 min read
Drug Development

Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences

July 8, 2024
·
7 min read
News

C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day

July 8, 2024
·
1 min read
News

Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo

July 8, 2024
·
6 min read
News

Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher

July 8, 2024
·
6 min read
News

Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)

July 8, 2024
·
9 min read
Business

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results

July 8, 2024
·
1 min read
News

Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer

July 8, 2024
·
8 min read
News

Merus Announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 2L CRC

July 8, 2024
·
5 min read
Drug Development

Woolsey Pharmaceuticals Announces Treatment Of First Patient with Higher-Dose BRAVYL in The REAL Amyotrophic Lateral Sclerosis (ALS) Study (NCT05218668)

July 8, 2024
·
2 min read